This picture taken on September 9, 2020 shows a volunteer (L) attending an Alzheimers patients during lunch at the restaurant of the village Landais Alzheimer site for Alzheimers patients in Dax, southwestern France. (Photo by Philippe LOPEZ / AFP) (Photo by PHILIPPE LOPEZ/AFP via Getty Images)

Double board-certified neurologist Dr. Russell Surasky on experimental Alzheimer’s drug

There is a promising new experimental drug available for those with Alzheimer’s, made by Eli Lilly. The company reports that in a late-stage trial, it slowed the progression of the disease by 35%. The Alzheimer’s Association predicts that the number of Americans living with Alzheimer’s will increase from over 6 million now to almost 13 million by 2050. Double Board Certified Neurologist,

Read More Double board-certified neurologist Dr. Russell Surasky on experimental Alzheimer’s drug